Home    Back

 122. Superficial siderosis
 [ 2 clinical trials,    1 drug(DrugBank: 1 drug),    0 target gene / 0 target pathway

Searched query = "Superficial siderosis", "Brain table hemosiderosis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-jRCTs03118043801/04/201910 September 2019Evaluation of iron chelator administration, and cochlear implantation for superficial siderosisEvaluation of iron chelator administration, and cochlear implantation for superficial siderosis - ECHACISSSuperficial siderosis
siderosis, cerebellar ataxia, hearing loss, superficial siderosis
1. Administration of Deferiprone orally 30mg/kg after every meal for 36 months.
2. Artificial cochlear implantation for severe hearing disturbance
Nobuo SanjoRecruiting20ageNot applicableBoth50N/Anone
2JPRN-UMIN0000212182012/05/172 April 2019An efficacy of iron chelator to superficial siderosissuperficial siderosis of CNSdeferiproneDepartment of NeurologyRecruiting20years-oldNot applicableMale and Female5Not applicableJapan